PubRank

D G Colin-Jones

Author PubWeight™ 71.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994 6.89
2 Postmarketing surveillance of the safety of cimetidine: 12 month mortality report. Br Med J (Clin Res Ed) 1983 2.90
3 Mucosal changes in gastric ulceration and their response to carbenoxolone sodium. Gut 1975 2.57
4 Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study. Br Med J (Clin Res Ed) 1982 2.40
5 Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcers. Lancet 1984 2.25
6 Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up. Br Med J (Clin Res Ed) 1985 1.78
7 Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 2000 1.69
8 Mistletoe hepatitis. Br Med J (Clin Res Ed) 1981 1.50
9 Letter: Steatorrhoea complicating therapy with mefenamic acid. Br Med J 1976 1.48
10 Review article: over-the-counter drugs and the gastrointestinal tract. Aliment Pharmacol Ther 2001 1.45
11 The location of the chemoreceptor controlling gastric acid secretion during hypoglycaemia. J Physiol 1970 1.40
12 Modern management of peptic ulceration. Br J Hosp Med 1992 1.40
13 Current endoscopic practice in the United Kingdom. Clin Gastroenterol 1978 1.40
14 Trichobezoar, gastric polyposis, protein-losing gastroenteropathy and steatorrhoea. Gut 1973 1.37
15 The secretion of gastric acid in response to a lack of metabolizable glucose. J Physiol 1969 1.35
16 The assay of gastrin using the perfused rat stomach. Br J Pharmacol 1970 1.28
17 Gastrointestinal endoscopy services--a review of the 70s with predictions for the 80s. Health Trends 1982 1.20
18 Routine practice in the diagnosis of adenocarcinoma of the stomach: a survey of tumours diagnosed in the Portsmouth and Oxford Health Districts 1979-1980. Postgrad Med J 1988 1.17
19 Accuracy and value of the Hemoccult test in symptomatic patients. Br Med J (Clin Res Ed) 1983 1.17
20 Letter: Reversal of metiamide-induced agranulocytosis during treatment with cimetidine. Lancet 1975 1.14
21 Oesophageal motor function before and after healing of oesophagitis. Gut 1992 1.13
22 Acid suppression: how much is needed? BMJ 1990 1.07
23 Letter: Upper-gastrointestinal endoscopy. Lancet 1975 1.05
24 Endoscopy or radiology for upper gastrointestinal symptoms? Lancet 1986 1.02
25 A case of scurvy. Br Med J (Clin Res Ed) 1986 1.01
26 Improving the standards of endoscopy. Gut 1991 0.96
27 What is a normal upper gastrointestinal tract? BMJ 1991 0.94
28 Melanosis coli: studies of the toxic effects of irritant purgatives. J Pathol 1975 0.92
29 Controlled comparison of cimetidine and carbenoxolone sodium in gastric ulcer. Br Med J 1979 0.90
30 Malignant Zollinger-Ellison syndrome with gastrin-containing skin metastases. Lancet 1969 0.90
31 Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present. Am J Gastroenterol 1994 0.88
32 Studies on the pathogenesis of the early dumping syndrome induced by intraduodenal instillation of hypertonic glucose. Gut 1989 0.86
33 Clinical evaluation of the 14C fat absorption test. Gut 1974 0.86
34 There is more to healing ulcers than suppressing acid. Gut 1986 0.86
35 The location of the chemoreceptor controlling gastric acid secretion during hypoglycaemia. Clin Sci 1969 0.84
36 Treatment of air embolism with hyperbaric oxygen. Br Med J (Clin Res Ed) 1985 0.84
37 Provision of ERCP services and training in the United Kingdom. Endoscopy 2000 0.84
38 Factors which determine the gastric secretory response to 2-deoxy-D-glucose. Gut 1969 0.83
39 Recurrent retching with gastric mucosal prolapse. A proposed prolapse gastropathy syndrome. Dig Dis Sci 1984 0.83
40 Prolonged remission of oesophagitis does not alter the magnitude of oesophageal acid exposure. Scand J Gastroenterol 1994 0.82
41 Chronic, non-visceral abdominal pain. Gut 1994 0.82
42 Proceedings: Human mast cell degranulation and vacuolation. J Anat 1974 0.81
43 Proceedings: The effects of aspirin, carbenoxolone, and gefarnate on the gastric mucosal potential difference in man. Gut 1974 0.80
44 Simultaneous two level oesophageal pH monitoring in healthy controls and patients with oesophagitis: comparison between two positions. Gut 1994 0.80
45 Endoscopic removal of a large ulcerated Brunner's gland adenoma. Endoscopy 1986 0.80
46 Proceedings: Bird fancier's lung and coeliac disease. Gut 1975 0.79
47 Proceedings: Measurement of gastric mucosal potential difference at endoscopy. Gut 1975 0.78
48 Future needs for ERCP: incidence of conditions leading to bile duct obstruction and requirements for diagnostic and therapeutic biliary procedures. Gut 1990 0.78
49 Problems of peptic ulceration in the elderly. Postgrad Med J 1975 0.78
50 Guidelines for the management of dyspepsia. Eur J Gastroenterol Hepatol 1999 0.77
51 The detection and measurement of circulating gastrin-like activity by bioassay. Gut 1972 0.77
52 Comparison of ranitidine and cimetidine maintenance treatment of duodenal ulcer. Scand J Gastroenterol 1984 0.77
53 The evaluation of a gastric bile probe. Nucl Med Commun 1990 0.76
54 Postmarketing surveillance of the safety of cimetidine: 15-year mortality report. Pharmacoepidemiol Drug Saf 1998 0.76
55 Pharmacological response to cimetidine and healing of duodenal ulceration: effects of high-dose cimetidine and combination of cimetidine with pirenzepine. Aliment Pharmacol Ther 1988 0.76
56 Potential difference across the normal and the abnormal gastric mucosa in man. Gut 1976 0.76
57 Reducing overnight secretion of acid to heal duodenal ulcers. Comparison of standard divided dose of ranitidine with a single dose administered at night. Am J Med 1984 0.75
58 Helicobacter pylori and non-steroidal anti-inflammatory drugs: lone agents or partners in crime? Eur J Gastroenterol Hepatol 1997 0.75
59 Helicobacter pylori and surgery. Authors should not extrapolate findings into unresearched areas. BMJ 1998 0.75
60 Gastrointestinal endoscopy: to sedate or not to sedate? Endoscopy 1996 0.75
61 Gastric ulcer: is endoscopy always necessary? Br Med J (Clin Res Ed) 1981 0.75
62 Drug-induced gastrointestinal ulceration: a review. J R Soc Med 1980 0.75
63 Acute renal failure associated with acute pyelonephritis and consumption of non-steroidal anti-inflammatory drugs. Br Med J (Clin Res Ed) 1986 0.75
64 Steerable catheter. Dig Dis Sci 1982 0.75
65 A novel approach to the management of oesophageal tube overgrowth by tumour. Endoscopy 1994 0.75
66 Porous containers for small biopsy specimens. Lancet 1982 0.75
67 Ranitidine in the management of acute duodenal ulcer. Indian J Gastroenterol 1986 0.75
68 A new endo-oesophageal tube. J R Coll Surg Edinb 1988 0.75
69 Cimetidine in the management of gastric ulceration. Scott Med J 1977 0.75
70 Gastric acid secretion in response to a lack of metabolizable glucose. Gut 1968 0.75
71 Endoscopy in the diagnosis of gastrointestinal disorders. Practitioner 1983 0.75
72 Effect of carbenoxolone sodium upon ionic movement across the gastric mucosa in patients with gastric ulcers. Gut 1973 0.75
73 Economical basis of digestive disorders management with special emphasis on endoscopy. Pol Arch Med Wewn 1986 0.75
74 Factors determining the onset and cessation of gastric acid secretion provoked by 2-deoxy-D-glucose. Br J Surg 1969 0.75
75 Ranitidine in the management of gastric ulcer. Indian J Gastroenterol 1986 0.75
76 Gastroenterology in 20 years' time. Practitioner 1987 0.75